NeoGenomics to Participate in Upcoming Investor Conferences
NeoGenomics (NASDAQ:NEO), a leading oncology testing services company, has announced its participation in three major upcoming investor conferences in March:
- TD Cowen 45th Annual Health Care Conference in Boston, MA, featuring a fireside chat on March 4 at 1:50 p.m. ET
- Leerink Partners Global Healthcare Conference in Miami, FL, with a fireside chat scheduled for March 11 at 3:30 p.m. ET
- Barclays 27th Annual Global Healthcare Conference in Miami, FL, hosting a fireside chat on March 13 at 9:00 a.m. ET
All sessions will be available via live and archived webcasts through the Investor Relations section of NeoGenomics' website at ir.neogenomics.com.
NeoGenomics (NASDAQ:NEO), una delle principali aziende di servizi di test oncologici, ha annunciato la sua partecipazione a tre importanti conferenze per investitori in programma a marzo:
- TD Cowen 45a Conferenza Annuale sulla Salute a Boston, MA, con un incontro informale il 4 marzo alle 13:50 ET
- Leerink Partners Global Healthcare Conference a Miami, FL, con un incontro informale previsto per l'11 marzo alle 15:30 ET
- Barclays 27a Conferenza Annuale Globale sulla Salute a Miami, FL, che ospiterà un incontro informale il 13 marzo alle 9:00 ET
Tutte le sessioni saranno disponibili tramite webcast in diretta e registrati nella sezione Relazioni con gli Investitori del sito web di NeoGenomics all'indirizzo ir.neogenomics.com.
NeoGenomics (NASDAQ:NEO), una de las principales empresas de servicios de pruebas oncológicas, ha anunciado su participación en tres importantes conferencias para inversores programadas para marzo:
- TD Cowen 45ª Conferencia Anual de Salud en Boston, MA, con un chat informal el 4 de marzo a la 1:50 p.m. ET
- Leerink Partners Global Healthcare Conference en Miami, FL, con un chat informal programado para el 11 de marzo a las 3:30 p.m. ET
- Barclays 27ª Conferencia Anual Global de Salud en Miami, FL, que albergará un chat informal el 13 de marzo a las 9:00 a.m. ET
Todas las sesiones estarán disponibles a través de transmisiones en vivo y grabadas en la sección de Relaciones con Inversores del sitio web de NeoGenomics en ir.neogenomics.com.
NeoGenomics (NASDAQ:NEO), 주요 종양학 테스트 서비스 회사가 3월에 열리는 세 가지 주요 투자자 회의에 참여한다고 발표했습니다:
- TD Cowen 제45회 연례 건강 관리 회의가 매사추세츠주 보스턴에서 열리며, 3월 4일 오후 1시 50분 ET에 비공식 대화가 예정되어 있습니다.
- Leerink Partners 글로벌 건강 관리 회의가 플로리다주 마이애미에서 열리며, 3월 11일 오후 3시 30분 ET에 비공식 대화가 예정되어 있습니다.
- Barclays 제27회 연례 글로벌 건강 관리 회의가 플로리다주 마이애미에서 열리며, 3월 13일 오전 9시 ET에 비공식 대화가 진행됩니다.
모든 세션은 NeoGenomics 웹사이트의 투자자 관계 섹션(ir.neogenomics.com)을 통해 생중계 및 아카이브된 웹캐스트로 제공됩니다.
NeoGenomics (NASDAQ:NEO), une entreprise leader dans les services de tests oncologiques, a annoncé sa participation à trois grandes conférences pour investisseurs prévues en mars :
- Conférence annuelle sur la santé TD Cowen à Boston, MA, avec une discussion informelle le 4 mars à 13h50 ET
- Conférence mondiale sur la santé de Leerink Partners à Miami, FL, avec une discussion informelle prévue pour le 11 mars à 15h30 ET
- 27e conférence annuelle mondiale sur la santé de Barclays à Miami, FL, qui accueillera une discussion informelle le 13 mars à 9h00 ET
Toutes les sessions seront disponibles en direct et en archive via des webcasts dans la section Relations avec les investisseurs du site Web de NeoGenomics à l'adresse ir.neogenomics.com.
NeoGenomics (NASDAQ:NEO), ein führendes Unternehmen im Bereich der Onkologie-Testdienstleistungen, hat seine Teilnahme an drei wichtigen bevorstehenden Investorenkonferenzen im März angekündigt:
- TD Cowen 45. Jahrestagung für Gesundheitswesen in Boston, MA, mit einem informellen Gespräch am 4. März um 13:50 Uhr ET
- Leerink Partners Global Healthcare Conference in Miami, FL, mit einem informellen Gespräch, das für den 11. März um 15:30 Uhr ET geplant ist
- Barclays 27. Jahrestagung für globales Gesundheitswesen in Miami, FL, die am 13. März um 9:00 Uhr ET ein informelles Gespräch ausrichtet
Alle Sitzungen werden über Live- und archivierte Webcasts im Bereich Investor Relations der NeoGenomics-Website unter ir.neogenomics.com verfügbar sein.
- None.
- None.
-
TD Cowen 45th Annual Health Care Conference in
Boston, MA
Fireside chat on Tuesday, March 4 at 1:50 p.m. ET, accessible here -
Leerink Partners Global Healthcare Conference in
Miami, FL
Fireside chat on Tuesday, March 11 at 3:30 p.m. ET, accessible here -
Barclays 27th Annual Global Healthcare Conference in
Miami, FL
Fireside chat on Thursday, March 13 at 9:00 a.m. ET, accessible here
Live and archived webcasts of the sessions may be viewed on the Investor Relations section of the Company’s website at ir.neogenomics.com.
About NeoGenomics
NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250224577544/en/
Investor Contact
Kendra Sweeney
Kendra.sweeney@neogenomics.com
Media Contact
Andrea Sampson
asampson@sampsonprgroup.com
Source: NeoGenomics, Inc.
FAQ
When is NeoGenomics (NEO) presenting at the TD Cowen Healthcare Conference?
What investor conferences is NeoGenomics (NEO) attending in March 2024?
How can investors access NeoGenomics (NEO) conference presentations?
What time is NeoGenomics (NEO) presenting at the Barclays Healthcare Conference?
